DarioHealth Corp. (DRIO) News
Filter DRIO News Items
DRIO News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
DRIO News Highlights
- For DRIO, its 30 day story count is now at 3.
- Over the past 6 days, the trend for DRIO's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- GLP are the most mentioned tickers in articles about DRIO.
Latest DRIO News From Around the Web
Below are the latest news stories about DARIOHEALTH CORP that investors may wish to consider to help them evaluate DRIO as an investment opportunity.
National Employer Selects Dario Cardiometabolic and GLP-1 Solutions to Improve Employee HealthDarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today a new contract to provide cardiometabolic and GLP-1 solutions to a national employer (the "Employer") beginning in January 2024. |
Is It Too Late To Consider Buying DarioHealth Corp. (NASDAQ:DRIO)?DarioHealth Corp. ( NASDAQ:DRIO ), is not the largest company out there, but it led the NASDAQCM gainers with a... |
Blue Shield of California's Award-Winning Wellvolution Now More Accessible for Spanish Speakers, Adds New Hypertension OfferingBlue Shield of California is making its award-winning digital health platform Wellvolution more accessible for Spanish-speakers and expanding its program with the addition of Dario, an at-home solution for high blood pressure, or hypertension, that combines personalized health coaching and tech-enabled monitoring. |
Dario Contracts with New Employer for Cardiometabolic SolutionDarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today a new contract to provide its cardiometabolic solution to an employer (the "Employer") beginning in January 2024. |
New Research Sheds Light on Mediators of Improved Outcomes in Dario UsersDarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today two new analyses recently presented by Sanofi U.S. demonstrating two mediators associated with improved clinical and economic in Dario users. |
Dario Publishes New Research Demonstrating that Dario Users That Increased Physical Activity Can Maintain Reduced Blood GlucoseDarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced new research presented at the Diabetes Technology Society 2023 Meeting on November 7, 2023. The new research demonstrated the value of associating physical activity tracking alongside blood sugar tracking for people living with diabetes and pre-diabetes. |
DarioHealth Corp. (NASDAQ:DRIO) Analysts Just Trimmed Their Revenue Forecasts By 13%The latest analyst coverage could presage a bad day for DarioHealth Corp. ( NASDAQ:DRIO ), with the analysts making... |
DarioHealth Reports Third Quarter 2023 Financial and Operating ResultsDarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today reported financial results for the third quarter 2023 and provided a corporate and commercial update. |
Dario Launches Apple iPhone 15 Accessible Smart Blood Glucose MeterDarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced the launch of a new smart blood sugar meter for Apple iPhone 15 users to support ongoing engagement with new and existing members. |
DarioHealth to Report Third Quarter 2023 Results on Thursday, November 2ndDarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital health market, today announced that it will release its financial results for the third quarter ended September 30, 2023, on Thursday, November 2, 2023, before market opens and will host a conference call and webcast at 8:30 am Eastern Time. |